COVID-19 Vaccine Acceptance: Ethical, Legal and Social Aspects (ELSA)
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (1 September 2023) | Viewed by 17699
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite its relatively high accessibility and low burden of adherence, and despite the significant progress in science, efficacy, safety, and healthcare planning, as well as its established success, the acceptance of vaccination, especially COVID-19 vaccination, has been especially challenging. Vaccine acceptance has received increasing attention over the last two decades. As challenges to vaccine acceptance have arisen, there have also been significant changes in cultural and social climates, the communication landscape, political polarization, and the environment that may contribute to this challenge. In this Special Issue, we invite academic reflections on vaccine acceptance, insights from a broad range of disciplines that target diverse factors that may be related to vaccine acceptance, and interventions that may show promise to address these challenges that particularly focus on the roles of cultural, social, political, and ethical interests.
Dr. Rachael N. Piltch-Loeb
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine (acceptance, hesitancy)
- history
- healthcare policy
- ELSA
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.